These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36119757)

  • 1. Successful treatment of rhino-cerebral mucormycosis with dual antifungal therapy and minimal surgical debridement.
    Bougioukas L; Noyes CD; Peterson K; Smith LM; Hale AJ
    IDCases; 2022; 30():e01615. PubMed ID: 36119757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of
    Miller RP; Farrugia L; Leask J; Khalsa K; Khanna N; Melia L
    Med Mycol Case Rep; 2021 Jun; 32():39-42. PubMed ID: 33816097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-Orbito-Cerebral Mucormycosis: A Challenging Case.
    El Hakkouni A; Harrar S; Hachimi A; Mezouari M; Moutaj R
    Cureus; 2023 Sep; 15(9):e44768. PubMed ID: 37809164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.
    Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O
    Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    Guimarães JA; Moura FC
    Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rhino-orbito-cerebral mucormycosis: two case reports in the light of the literature].
    Kara M; Erdoğan H; Toroslu T; Akçalı A; Tatman Okun M; Reşorlu M; Dereköy FS
    Kulak Burun Bogaz Ihtis Derg; 2015; 25(5):295-301. PubMed ID: 26476519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report.
    Monroig V; Tarquinio KM
    J Med Case Rep; 2022 Oct; 16(1):400. PubMed ID: 36316719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhino-Orbital Cerebral Mucormycosis: A Fatal Evolution.
    Benlamkaddem S; Zdaik G; Doughmi D; Bennis A; Chraibi F; Berdai MA; Abdellaoui M; Benatiya Andaloussi I; Harandou M
    Cureus; 2023 Apr; 15(4):e37837. PubMed ID: 37214071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature.
    Torabiyan S; Dalfardi B; Sanjari M
    Case Rep Endocrinol; 2021; 2021():2765867. PubMed ID: 34777880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhino-orbito-cerebral mucormycosis: five cases.
    Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
    Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease.
    Andreani G; Fadda G; Gned D; Dragani M; Cavallo G; Monticone V; Morotti A; De Gobbi M; Guerrasio A; Barbui AM; D'Avolio A; Cilloni D
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019061. PubMed ID: 31700586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhino-Orbital Cerebral Mucormycosis in a Non-diabetic Patient Following COVID-19 Infection: A Case Report and Literature Review.
    Niazi M; Vittorino I; Thwe H; Alam B; Awosika AO; Omole AE
    Cureus; 2022 Dec; 14(12):e32884. PubMed ID: 36699798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole.
    Yoon YK; Kim MJ; Chung YG; Shin IY
    J Korean Neurosurg Soc; 2010 Jan; 47(1):74-7. PubMed ID: 20157385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report.
    Alemayehu FM; Abate HK; Soboka TA; Huluka DK; Worke AB; Abrie MT; Dibaba DK; Asnake YB
    Int Med Case Rep J; 2022; 15():251-257. PubMed ID: 35615254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhino-Orbital-Cerebral Mucormycosis in a Post-COVID-19 Patient from Peru.
    Ponce-Rosas L; Gonzales-Zamora J; Diaz-Reyes N; Alarco-Cadillo O; Alave-Rosas J
    Case Rep Infect Dis; 2022; 2022():2537186. PubMed ID: 35299936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful long-term therapy of mucormycosis with isavuconazole.
    Brigmon MM; Ochoa B; Brust K
    Proc (Bayl Univ Med Cent); 2021; 34(6):703-704. PubMed ID: 34732994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.